The effect of prophylactic use of pethidine for anxiety and post procedural pain relief in patients undergoing percutaneous liver biopsy

Not Applicable

Completed

• Conditions: Patient undergoing percutaneous liver biopsy; Anaesthesiology - Pain management; Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon

• Registration Number: ACTRN12614001194651
• Lead Sponsor: Gastroenterology unit, Dunedin Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2014-11-13
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

All patients undergo percutaneous liver biopsy at Dunedin hospital

Exclusion Criteria

1) Patients with previous allergic reaction to pethidine or metoclopramide; 2) Patients with clotting disorders and abnormal prothrombin time with international normalized ratio (INR) of greater than 1.5 or thrombocytopenia with platelet less than 50 x 109 per litre; 3) abdominal ultrasound revealed a contraindication to PLB such as massive ascites, intrahepatic duct dilatation, or focal lesion; 4) patients without a telephone for study follow up; and 5) patients with a solitary lesion that required target biopsy under ultrasound guidance

Study & Design

• Study Type: Interventional
• Study Design: Not specified